Triple-negative breast cancers (TNBCs) are a subcategory of breast carcinomas that do not overexpress the human epidermal growth factor receptor 2 (HER2) and lack expression of the estrogen (ER) and progesterone (PR) receptors (1). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.